How TTP solves retina’s toughest challenges: from precision drug delivery to surgical device innovation
Whether you’re advancing new delivery methods for targeted gene therapies or developing a next generation endoprobe, TTP’s scientists, engineers, and designers help you overcome the barriers to progress.
Our cross-functional teams in ocular drug delivery and ophthalmic device development bring together deep technical expertise to navigate the intersection of complex formulations, delivery constraints, and surgical precision.
"Their experience in the ophthalmic field enhanced their understanding of our objectives and resulted in creative solutions to complex optical and opto-mechanical design issues."
— Terry Fuller, CEO, Third Eye Diagnostics
Cross-functional expertise where it matters most
Retinal interventions demand novel thinking - both in how drugs are delivered and how surgeries are performed. Targeted, localised delivery requires careful alignment between formulation, route, and device design.
At the same time, surgical access to the retina is delicate and high-risk, where precision tools can have a significant impact on outcomes. Yet in both cases, critical challenges often surface late. We help you identify and solve these issues early, so you can reduce risk, accelerate development, and move forward with confidence.
How TTP helps you deliver breakthrough retinal interventions
- Developing devices that make complex retinal procedures safer, more controlled and efficient
- Designing ocular drug delivery solutions around the formulation, not the other way around
- Improving retinal tools and sub-retinal delivery devices that address real pain points
- Developing surgical tools that assist with subretinal injection and dose control
- Shifting surgical protocols into outpatient or office-based settings
Read more about our work in action:
Ocular drug delivery solutions
Ophthalmology and optometry device design and development
We’ll be at the Retina Innovation Summit - will you?
Bring us your toughest delivery or surgical challenge. We’re ready to help you solve it. With nearly 40 years of experience, we’ve supported leading pharmaceutical companies and ambitious startups in bringing breakthrough MedTech innovations to life.